KNSTRN and melanoma: This variant was first reported in 2014 as a missense p.Ser24Phe substitution in KNSTRN and was described in 19% of cutaneous squamous cell carcinomas (SCCs), a less aggressive skin cancer subtype derived from keratinocytes, as well as in 5% of melanoma tumors [16].